Given the high similarity between FLI1 and ERG and the encouraging preliminary results obtained with YK-4-279 in PCa preclinical models overexpressing ERG (see Section 5), TK-216 might represent a promising therapeutic strategy for the treatment for PCa patients harboring tumors overexpressing ERG. The gene discussed is FLI1; the disease is posterior cortical atrophy.